Precisiongenome Engineering

Seattle, WA 98103

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $2.13MM
First Award Date 09/01/09
Most Recent Award Date 07/01/14

Key Personnel

Last Name Name Awards Contact
Beitz Laurie O. Beitz 2
Jarjour Jordan Jarjour 1
Scharenberg Andrew M Scharenberg 1
Burks Christian Burks 1 Message
ASTRAKHAN ALEXANDER ASTRAKHAN 1

6 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-12-089
Budget: 07/01/14 - 06/30/15

DESCRIPTION (provided by applicant): Treating patients infected with Human Immunodeficiency Virus-1 (HIV-1) is a substantial clinical challenge with evolving pharmaceutical drug and dosing options. Treatments should improve the health and quality of life for HIV-infected individuals by reducing viremia and preserving immunological function. Curr...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-12-089
Budget: 09/27/13 - 06/30/14

DESCRIPTION (provided by applicant): Treating patients infected with Human Immunodeficiency Virus-1 (HIV-1) is a substantial clinical challenge with evolving pharmaceutical drug and dosing options. Treatments should improve the health and quality of life for HIV-infected individuals by reducing viremia and preserving immunological function. Curr...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 09/05/12 - 09/04/13

DESCRIPTION (provided by applicant): Genome engineering is an emerging field in which genomic DNA sequences are modified for biotechnological and therapeutic purposes. Highly specific endonucleases are the key tool that enables genome engineering approaches, as they are required to create double-stranded DNA breaks at defined genomic sequences. ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 06/01/10 - 05/31/12

DESCRIPTION (provided by applicant): Genome engineering is an emerging field in which targeted genome modifications are made for biotechnological and therapeutic applications. Site specific rare cutting endonucleases are a crucial tool for genome engineering, as they are required to create DNA double strand breaks at specific genomic targets....

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-OD-09-009
Budget: 04/05/10 - 03/31/11

DESCRIPTION (provided by applicant): Genome engineering is an emerging field in which site specific rare cutting endonucleases are used to create DNA double strand breaks at desired genomic sites. Endonuclease-induced double strand breaks are resolved by endogenous DNA repair pathways, resulting in high efficiency gene editing if resolved via no...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-08-051
Budget: 09/01/09 - 02/28/11

DESCRIPTION (provided by applicant): State the application's broad, long-term objectives and specific aims, making reference to the health relatedness of the project (i.e., relevance to the mission of the agency). Describe concisely the research design and methods for achieving these goals. Describe the rationale and techniques you will use to p...